Concepedia

Matthew M. Riggs

MM

Statistics

Publications

10

Citations

423

H-Index

10

Active since

2009

Affiliations

Metrum Research Group (United States)(Current)

Boehringer Ingelheim (Germany)

Boehringer Ingelheim (United States)

Pfizer (United States)

Boehringer Ingelheim (Canada)

Matthew M. Riggs is an author at Metrum Research Group (United States) specializing in pharmacology, pharmacokinetic modeling, and clinical pharmacology.

ORCID

Publications per year

2009–2021

10

Publications

10

A physiologically based mathematical model of integrated calcium homeostasis and bone remodeling

Mark Peterson, Matthew M. Riggs · Bone · 2009 · 196 citations

, , +16

<scp>Quantitative Systems Pharmacology</scp>and<scp>Physiologically‐Based Pharmacokinetic</scp>Modeling With mrgsolve: A Hands‐On Tutorial

Ahmed Elmokadem, Matthew M. Riggs, Kyle Baron · CPT Pharmacometrics & Systems Pharmacology · 2019 · 83 citations · Full text

, , +17

Multiscale Physiology‐Based Modeling of Mineral Bone Disorder in Patients With Impaired Kidney Function

Matthew M. Riggs, Mark Peterson, Marc R. Gastonguay · The Journal of Clinical Pharmacology · 2012 · 31 citations

, , +17

Population pharmacokinetics of empagliflozin, a sodium glucose cotransporter 2 inhibitor, in patients with type 2 diabetes

Matthew M. Riggs, Alexander Staab, Leo Seman et al. · The Journal of Clinical Pharmacology · 2013 · 30 citations

, , +13

A Quantitative Modeling and Simulation Framework to Support Candidate and Dose Selection of Anti‐SARS‐CoV‐2 Monoclonal Antibodies to Advance Bamlanivimab Into a First‐in‐Human Clinical Trial

Emmanuel Chigutsa, Eric Jordie, Matthew M. Riggs et al. · Clinical Pharmacology & Therapeutics · 2021 · 24 citations · Full text

, , +17

1–5 of 10